A detailed history of Mizuho Securities Usa LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mizuho Securities Usa LLC holds 118,118 shares of GILD stock, worth $12.5 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
118,118
Previous 80,731 46.31%
Holding current value
$12.5 Million
Previous $6.77 Million 61.25%
% of portfolio
0.22%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$83.95 - $97.9 $3.14 Million - $3.66 Million
37,387 Added 46.31%
118,118 $10.9 Million
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $4.28 Million - $5.39 Million
64,232 Added 389.31%
80,731 $6.77 Million
Q3 2024

Nov 06, 2024

SELL
$66.59 - $83.99 $5.3 Million - $6.68 Million
-79,561 Reduced 82.82%
16,499 $1.38 Million
Q2 2024

Jul 31, 2024

BUY
$63.15 - $72.88 $6.07 Million - $7 Million
96,060 New
96,060 $6.59 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $133B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.